Directories

Yaniv Heled

Publications

Articles and Other Contributions to Law Reviews and Scholarly Journals

Yaniv Heled, Patents vs. Statutory Exclusivities in Biological Pharmaceuticals - Do We Really Need Both?, 18 Mich. Telecomm. & Tech. L. Rev. 419 (2012). | LexisNexis | Westlaw | SSRN

Yaniv Heled, Why Primary Patents Covering Biologics Should Be Unenforceable Against Generic Applicants Under the Biologics Price Competition and Innovation Act, 21 Annals Health L. 211 (2012). | Westlaw

Yaniv Heled, The Regulation of Genetic Aspects of Donated Reproductive Tissue - The Need for Federal Regulation, 11 Colum. Sci. & Tech. L. Rev. 243 (2010). | LexisNexis | Westlaw

Yaniv Heled, On Presidents, Agencies, and the Stem Cells Between Them: A Legal Analysis of President Bush's and the Federal Government’s Policy on the Funding of Research Involving Human Embryonic Stem Cells, 60 Admin. L. Rev. 65 (2008). | Hein | LexisNexis | Westlaw

Articles and Other Contributions to Non-Academic Publications

Yaniv Heled, Why Deny Parents New Technology?, Haaretz, May 24, 2005, at B2. | www

Electronic Publications

Frederick H. Rein, Scott A. Warren, & Yaniv Heled, Healthcare Reform Creates Pathway for Biosimilar Biologics, ipFrontline (Apr. 9, 2010), available at http://www.ipfrontline.com/depts/article.aspx?id=24198&deptid=4. | www